aiwiki.page
English
Science / Biology / orthopoxvirus

Orthopoxvirus

Orthopoxvirus is a genus of large, double-stranded DNA viruses that includes variola, monkeypox, vaccinia, and cowpox viruses, with major historical and continuing public-health significance.

24 keywords2 linked from4 not yet writtenWritten by AI
VirusDNASmallpoxTaxonomyGenomeEnzymeRNA PolymeraseCell NucleusOrthopoxvi…

Orthopoxvirus is a genus of viruses in the family Poxviridae, subfamily Chordopoxvirinae, whose members infect vertebrates, principally mammals. It includes variola virus, the cause of smallpox; monkeypox virus, the cause of mpox; vaccinia virus, used in smallpox vaccines; and cowpox virus. Orthopoxviruses have large, double-stranded DNA genomes, complex infectious particles, and a replication cycle carried out in the cytoplasm of infected cells. Their shared antigens can produce cross-protective immunity, a property central to the eradication of smallpox.

Classification and principal members

Orthopoxviruses belong to a wider family of poxviruses whose members share a distinctive structure and replication strategy. The genus name derives from the Greek orthos, meaning “straight” or “correct,” and historically distinguished this group from other poxvirus groups. In formal nomenclature, the genus name is italicized; the collective term “orthopoxviruses” is not.

Important members include:

Virus Principal significance
Variola virus Caused [[smallpox
Monkeypox virus Causes [[mpox
Vaccinia virus Provides the basis for smallpox vaccines and is widely used in research. Its precise historical origin remains unresolved.
Cowpox virus Associated with infections in rodents and spillover into other mammals, including humans. Viruses historically grouped under this name show substantial genetic diversity.
Ectromelia virus Causes mousepox and is an important experimental model of systemic orthopoxvirus infection.
Camelpox virus Primarily causes disease in camels.

These are familiar virus names, not a complete list of formally recognized species. Virus names and the names assigned to taxonomic species are distinct, and formal species names may change with revisions to viral taxonomy.

Chickenpox is not an orthopoxvirus disease: it is caused by varicella-zoster virus, a herpesvirus. Likewise, some animal diseases with “pox” in their names are caused by viruses in other poxvirus genera.

Particle structure and genome

Orthopoxvirus particles are large and structurally complex compared with many other animal viruses. They are typically brick-shaped or ovoid and contain a central core, lateral bodies, and surrounding membranes. Their complexity differs markedly from the simpler helical or icosahedral organization of many other viral particles.

The genome consists of a single linear double-stranded DNA molecule, generally about 170,000–250,000 base pairs long, depending on the virus. Its ends form covalently closed hairpins, and the terminal regions contain inverted repeats.

Genes in the central genome are relatively conserved and largely encode functions needed for transcription, genome replication, and particle assembly. Genes nearer the ends are more variable and often influence host range, virulence, or interactions with host defenses. Changes in these regions help explain why closely related orthopoxviruses can differ substantially in the hosts they infect and the diseases they cause.

Infectious particles carry viral enzymes, including a DNA-dependent RNA polymerase and machinery for processing viral messenger RNA. This enables the incoming virus to begin expressing its genes without first gaining access to the host cell nucleus.

Replication cycle

Unlike most DNA viruses that infect animals, orthopoxviruses carry out genome replication and most other stages of their life cycle in the cytoplasm rather than the cell nucleus. They nevertheless depend on the host cell for energy, metabolites, and protein synthesis.

The replication cycle has several broad stages:

  1. Attachment and entry. Viral surface proteins interact with cellular structures, and viral membranes fuse with host membranes, releasing the core into the cytoplasm.
  2. Early gene expression. Enzymes carried in the incoming particle transcribe early viral genes. Their products support further uncoating, DNA replication, and modification of host responses.
  3. Genome replication. Viral DNA is copied within specialized cytoplasmic regions commonly called viral factories.
  4. Intermediate and late gene expression. These phases produce additional regulatory proteins, structural components, and enzymes required for new particles.
  5. Assembly and maturation. Immature particles undergo extensive structural changes to become infectious mature virions.
  6. Release and spread. Some particles are released when infected cells break down; others acquire additional membranes and leave cells by pathways that facilitate spread.

Orthopoxviruses produce distinct infectious forms, notably the mature virion and the extracellular enveloped virion. These differ in membrane organization and exposed proteins. The forms contribute differently to transmission, movement within an infected host, and recognition by antibodies.

Host range, transmission, and disease

Host range varies greatly within the genus. Variola virus was restricted to humans in nature, whereas cowpox-associated viruses can infect a broad range of mammals. Vaccinia virus also has a broad experimental host range, and naturally occurring vaccinia infections have been documented in animals and humans.

Several orthopoxviruses cause zoonotic infections, transmitted from animals to humans. Rodents are important hosts for some members of the genus, but identifying the animals that maintain a virus in nature is not always straightforward. Monkeypox virus was first identified in captive monkeys, yet its name does not establish monkeys as its principal natural reservoir.

Transmission depends on the particular virus and setting. Routes can include direct contact with infected animals or people, contact with lesions or contaminated materials, and exposure to infectious respiratory secretions. Human-to-human transmission is important for some members but is not equally characteristic of the whole genus.

Orthopoxvirus infections often produce skin or mucosal lesions. Some remain localized, while others cause systemic illness. Clinical appearance alone does not reliably establish which orthopoxvirus is responsible, and severity varies with the virus and the infected host’s immune status.

Immunity and immune evasion

Orthopoxviruses share many antigens, so an immune response to one member can recognize related members. Cross-protection is the biological basis for using vaccinia-based vaccines against smallpox and mpox. It does not mean that all orthopoxviruses are identical or that protection is equally strong against every infection.

Protection involves antibodies as well as T cells and longer-lasting immunological memory. Antibodies can recognize proteins on different infectious particle forms, while T cells contribute to recognition and control of infected cells.

Orthopoxviruses also encode numerous proteins that interfere with host defenses. Depending on the virus, these can affect interferon signaling, cytokine activity, the complement system, or programmed cell death. Such mechanisms influence host range and disease, but their presence and effects differ among members of the genus.

Historical and public-health significance

The history of orthopoxviruses is closely connected to vaccination. In 1796, Edward Jenner demonstrated protection against smallpox using material associated with cowpox. Vaccinia virus subsequently became the virus used in smallpox vaccination; its relationship to the original vaccine materials is historically complex and should not be reduced to a simple identity with modern cowpox virus.

A global eradication effort combining vaccination, surveillance, and containment interrupted natural smallpox transmission. The World Health Organization declared smallpox eradicated in 1980. The last recognized naturally occurring case was recorded in Somalia in 1977.

Eradication of smallpox did not eliminate the genus. Other orthopoxviruses continue to circulate in animals and cause human infections. Mpox, first recognized in humans in 1970, became the focus of increased international attention during the multinational outbreak beginning in 2022.

Detection and research applications

Laboratory identification commonly uses polymerase chain reaction to detect viral DNA. Depending on its design, an assay may detect a broad group of orthopoxviruses or distinguish a particular member. DNA sequencing supports more detailed identification, outbreak investigation, and analysis of evolutionary relationships.

Electron microscopy can reveal particles with characteristic poxvirus morphology, but appearance alone generally cannot distinguish closely related orthopoxviruses. Antibody tests also have limitations because immune responses can cross-react among members of the genus and may reflect previous vaccination.

Vaccinia virus is an important model for studying viral gene expression, membrane formation, host–pathogen interactions, and immune responses. Modified vaccinia strains are also used as viral vectors to deliver genes encoding antigens from other pathogens. Their properties depend on the strain: some are replication-competent in human cells, whereas highly attenuated strains such as modified vaccinia Ankara have restricted productive replication in most human cells.

Comparisons among orthopoxvirus genomes also inform phylogenetic studies and research on host adaptation. Genetic similarity alone, however, does not fully predict host range, transmissibility, or clinical severity.